Daklinza (30, 60 mg Tablets)

Bristol-Myers Squibb

DAKLINZA contains Drug / Molecule called “DACLATASVIR”. It is used for the treatment of patients with chronic Hepatitis C virus (HCV).It inhibits the Hepatitis C Virus (HCV) nonstructural protein; by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

Category:

Indication

DACLATASVIR is used for treatment of patients with chronic Hepatitis C .

Note

Precaution

  • Cases of severe bradycardia and heart block have been observed when used in combination with sofosbuvir with or without other drugs that lower heart rate.
  • Daklinza should not be used during pregnancy or in women of childbearing potential not using contraception.

Related products